ULF WIINBERG - 03 Sep 2024 Form 4 Insider Report for MiNK Therapeutics, Inc. (INKT)

Role
Director
Signature
By: /s/ Christine Klaskin, Attorney-in-Fact
Issuer symbol
INKT
Transactions as of
03 Sep 2024
Net transactions value
+$15,002
Form type
4
Filing time
05 Sep 2024, 08:22:01 UTC
Previous filing
01 Jul 2024
Next filing
03 Oct 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction INKT Common Stock Award $15,002 +18,295 +17% $0.8200 123,705 03 Sep 2024 Direct F1
holding INKT Common Stock 278,300 03 Sep 2024 See Footnote F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Common Stock for each RSU. The RSUs were received in lieu of cash retainers for board and committee compensation. The RSUs will vest one month from the grant date.
F2 Shares are held in an irrevocable trust for the benefit of Mr. Wiinberg's family.